Introduction

152
Since the early Ocular Hypertension Treatment Studies (OHTS) [1] and 153 subsequent independent findings of others [2, 3] , central corneal thickness (CCT) 154 was identified as a factor related to the risk for developing primary open angle 155 glaucoma (POAG). In these studies, CCT was a powerful predictor for 156 developing POAG, with thinner corneas being associated with an increased risk 157 of developing POAG [1] [2] [3] and this risk was independent of the confounding 158 effects of CCT on intraocular pressure measurements [1, 3] . The thinner CCT is 159 also associated with an increased severity of visual field loss and a more rapid 160 progression of the disease [4] [5] [6] . Furthermore, ethnic differences in CCT are 161 correlated with increased risk of developing POAG and an increased severity of 162 the disease [7] . Thus, there is a profound link between CCT and the risk of 163 developing POAG. 164
165
In humans, there is a considerable variation in CCT, ranging from under 450 µm 166 to over 650 µm [8] [9] [10] with a mean CCT of approximately 550 µm [8] [9] [10] [11] [12] [13] . The 167 variation in CCT is a highly heritable ocular trait, the genomic contribution of CCT 168 is estimated to be near 90% [8, 9, 11, 14] . Two studies on monozygotic and 169 dizygotic twins from two different human populations confirmed the heritability, 170 with the Chinese population having a heritability of 0.88 [8] [9] and the population 171 in Australia and the United Kingdom having a heritability of 0.95 [8] . In addition, 172 there is considerable variation in CCT between different ethnic groups. Aghaian 173 et al. [15] found that African-Americans (mean CCT of 524 µm) and Japanese 174 (mean CCT of 538 µm) had significantly thinner corneas than the general 175 population. Others [10] have not observed the same differences for Japanese 176 populations; however; thinner corneas are consistently observed in the African-177
American populations [10, 13] . 178 179 Genome-wide association studies (GWAS) on different human populations have 180 identified a number of human loci/genes [16] [17] [18] associated with CCT. Several of 181 the loci contain genes associated with CCT that are risk factors for human 182 diseases, including ZNF496, which is associated with brittle cornea syndrome 183 [19] , and COL8A2, causing Fuch's endothelial corneal dystrophy [20, 21] . A 184 recent meta-analysis of over 20,000 individuals identified an additional 16 185 additional loci associated with CCT [22] . Six of these loci conferred a significant 186 risk for keratoconus, a disease characterized by an extremely thin cornea. This 187 study of a large population successfully identified many different genes that 188 contribute to the heritability of CCT and not surprisingly implicated collagens and 189 extracellular matrix pathways in the regulation of CCT. Although this represents a 190 significant increase in the number of genes involved in CCT, all of the loci only 191 account for approximately 8% of the additive variance of CCT in the European 192 population [22] . Taken together, these data reveal that this highly heritable trait, 193 CCT, is a complex trait. In fact, it could be so complex that the contribution of 194 many individual genomic elements would be difficult to prove, especially in a 195 genetically heterogeneous species like humans. 196
197
Attempting to define the link between CCT and POAG in a human GWAS is 198 complicated by the fact that one is comparing two complex traits. In this case, the 199 effect size has to be very large. Many of the early studies specifically looked for a 200 genetic/molecular association between CCT and POAG. The large GWAS meta-201 analysis of human CCT [22] identified many new loci associated with CCT. One 202 of the loci that conferred a significant risk for keratoconus (FNDC3B), was also 203 associated with POAG. Given the power of the study (20,0000 individuals) and 204 the small effect of individual SNPs on CCT, it is clear that the association of 205 individual SNPs with CCT and POAG will require an extremely larger (potentially 206 unrealistic) sample size. Leveraging the unique genotype of recombinant inbred 207 mouse strains can help to simplify such analysis. 208 209 heritability, H 2 = Vg/(Vg + Ve), the calculation of 10.054/(10.054 + 2.92) reveals 258 that H 2 = 0.78. Thus, CCT is a highly heritable trait across the BXD RI strains. 259
260
Using an unbiased forward genetic approach and the data collected from the 261 cohort of 61 BXD strains, we performed a genome-wide scan in an effort to 262 identify QTLs that modulate CCT. The genome-wide interval map ( Figure 3 ) 263 reveals one significant peak on chromosome 13 (13 to 19 Mb) and a suggestive 264 peak on chromosome 7 (42 to 57 Mb). An expanded view of the peak on 265 chromosome 13 is illustrated in Figure 4 along with a haplotype map of the BXD 266 strains. The strains with the thicker corneas in general tend to have the D2 allele; 267 while, strains with thinner corneas have the B6 allele. This is reflected in the 268 genome wide map by the presence of the green line in the peak on chromosome 269 13 that indicates that higher phenotypic values are associated with the D2 allele 270 ( Figure 3 ). The QTL on Chr. 13 ( Figure 4 ) rises above the significance level of 271 p<0.05 as indicated by the pink line. The significant portion of the peak extends 272 from 13Mb to 19Mb over Chr. 13. Genomic elements modulating CCT are 273 located in this region. To identify candidates for modulating CCT in the BXD RI 274 strains, we examined this 7Mb long region. The candidate genes can either be 275 genomic elements with cis-QTLs or they can be genes with nonsynonymous 276 SNPs changing protein sequence. Within this region are 29 traditional genes and 277 one microRNA. In the Whole Eye Database (Eye M430V2 (Sep08) RMA) hosted 278 on GeneNetwork.org we found two genes within this locus with cis-QTLs: Cdk13 279 and Mplkip. We examined the expression of both of these genes in the cornea 280 and the eye using quantitative PCR (Supplemental data 1, S1 Appendix). Neither 281 of the two genes were expressed at a high enough level in the cornea to be 282 monitored by microarrays of the whole eye. Thus, both genes were discounted 283 as potential candidates for modulating CCT. Within the significant QTL on Chr The genomic elements within significant QTLs on mouse chromosome 13 (13 to 296 19 Mb) were examined to determine if there were specific associations in two 297 human datasets: the International Glaucoma Genetics Consortium dataset for 298 association with CCT [22] , and the NEIGHBORHOOD glaucoma dataset 299
[29]. The syntenic regions on human chromosome 1 (235 to 238 Mb) and 300 chromosome 7 (38 to 43 Mb) were queried for associations of genetic effects 301 relative to human CCT and with genetic risk for human glaucoma. In the 302
International Glaucoma Genetics Consortium dataset for CCT [22] , there were a 303 number of nominally significant associations; however, none of the markers 304 remained significant after corrections for multiple testing. When we looked 305 specifically for the candidate genes from the mouse, weak associations were 306 found in both European populations (peak marker rs4723833; P=4.34x10 -3 β=-307 0.062µm) and Asian populations (peak marker rs17619647; P=3.72x10 -3 ; β=-308 0.066µm), both of these SNPs (rs4723833 and rs17619647) overlap POU6F2. 309
However, the associations are not significant after correction for multiple testing 310 of 482 SNPs in Europeans and 265 SNPs in Asians. The β values from this linear 311 regression analysis reflect the quantitative change in CCT per associated allele. 312
The mouse locus was also used to interrogate the NEIGHBORHOOD human 313 POAG glaucoma dataset [29] . In the NEIGHBORHOOD dataset, the top 50 314
SNPs associated with glaucoma within the syntenic region were all found within 315 the POU6F2 locus. The most significant SNP (rs76319873) had a genome-wide 316 p-value of 5.34 -6 and the next top 3 SNPs had p-values less than 10 -5 ( Figure 5 , 317 Table 1 ). None of these SNPs reached genome-wide significance when 318 corrected for multiple testing. 319 320
Distribution of POU6F2 in the Mouse Eye 321
Our data suggests that Pou6f2 modulates central corneal thickness and it may 322 also modulate risk for glaucoma in humans. To determine if Pou6f2 could be a 323 molecular link between CCT and glaucoma, we examined the distribution of 324 POU6F2 protein and mRNA in the retina and cornea in mice. The first approach 325 was to examine its absolute expression levels in adult retina and cornea using 326 digital droplet PCR. We first confirmed the specificity of tissue dissection using 327 the corneal marker Uroplakin 1 [30] , which was highly abundant in cornea but not 328 retina (5760±260 copies/µL vs. 3.3±0.9 copies/µL). The expression levels of 329
Pou6f2 were relatively high in the retina (76.3±1.5 copies/µL); however, levels of 330
Pou6f2 message from cornea were just above the detection threshold of digital 331 droplet PCR (0.5±0.2 copies/µL), suggesting that only few if any corneal cells 332 express Pou6f2. These data indicate that Pou6f2 was barely expressed in the 333 adult cornea, while it was readily detectable in the adult retina. 334
335
Previous studies [31] demonstrated that POU6F2 is expressed in neuroblasts in 336 the future ganglion cell layer of the developing eye and in retinal ganglion cells in 337 the adult mouse, cat and monkey. To confirm these findings and to examine the 338 potential for a link between RGCs and cornea, we immunostained sections from 339 the embryonic mouse eye, the adult mouse eye and flat-mounts of mouse retina. 340
In the embryonic eye, there is strong staining of the neuroblasts destined to 341 become retinal ganglion cells ( Figure 6 ). There is also notable staining of the 342 epithelium of the developing cornea and what appears to be corneal stem cells 343 were ganglion cells positive for RBPMS. There were a few cells in the inner 355 nuclear layer that were positive for POU6F2 and these cells were also positive 356 for RBPMS, identifying these cells as displaced ganglion cells. These data 357 demonstrate that POU6F2 is expressed in a small subset of retinal ganglion 358 cells. To provide additional evidence that the POU6F2 positive cells are ganglion 359 cells, we crushed the optic nerve unilaterally in three mice and allowed them to 360 survive for 28 days. The retinas were then examined for POU6F2 staining. No 361 labeling was observed in the RGC layer, indicating that all POU6F2 cells were 362 gone ( Figure 1 , S1 Appendix). Taken together, these data reveal that POU6F2 is 363 To determine if the POU6F2-positive RGCs are selectively sensitive to 370 glaucoma, we double stained 4 young DBA/2J (2 months old) mice for POU6F2 371 and RBPMS and compared these values to 4 aged (8-month-old) DBA/2J mice 372 ( Figure 8 ). When we counted the cells in the 4 young mice there were an 373 average of 460 (±81, SEM) RBPMS-labeled RGCs per 40X field. In the same 374 sections, we observed an average of 74 POU6F2-labeled RGCs (±15). When 375 these results were compared to 4 aged DBA/2J mice (8 months old) there was a 376 significant decrease (p<0.001, student t test) in the total number of RGCs to an 377 average of 361 RGCs (±21) per 40 X field. This represented a total decrease in 378 RBPMS labeled ganglion cells of 22%. When we examined POU6F2-positive 379 cells in the aged DBA/2J retinas there was a 73% loss of loss of cells, a 380 significant difference relative to young DBA/2J retinas (p<0.0001). The average 381 number of POU6F2 cells in the young retina was 74 (±5), while in the aged retina 382 this number decreased to 21 (±3). These data demonstrate that the POU6F2 383 RGC subtype is very sensitive to early phases of glaucoma in the DBA/2J model. 384
385
To examine the expression of POU6F2 in the cornea, we first examined sections 386 through the cornea and limbus extending down into the sclera. There was no 387 staining in the cornea or sclera. Occasionally, we observed individual cells 388 stained in the limbal area. However, it was difficult to unequivocally identify these 389 cells as limbal stem cells. As an alternative approach, we stained the surface of 390 six eyes using extended antibody incubation times. When examining the junction 391 between the cornea and sclera, a line of cells is stained at the junction between 392 the cornea and sclera in the limbus (Figure 9 ). This line of cells was also positive 393 for the stem cell marker ABCB5 ( Figure 9E ). Thus, POU6F2 is not only a marker 394 for limbal stem cells but it may be responsible in part for the maintenance of the 395 corneal integrity in the adult mouse eye. 396
397
To determine if POU6F2 is directly involved in corneal development and 398 maintenance affecting CCT, we examined the corneas of 8 Pou6f2-null mice and 399 compared their CCT to that from 10 wild-type littermates ( Figure 10 ). There was 400 a significant difference (p<0.01, Wilcoxon signed-rank test) in CCT between the 401 Pou6f2-null mice and the wild-type littermates. In the Pou6f2-null mice the mean 402 CCT was 102.8µm (±1.8µm). The wild-type littermates had a mean CCT of 403 109.9µm (±1.8µm). Thus, abolishing Pou6f2 expression has a significant effect 404 on CCT in the adult mouse. The BXD RI strain set is particularly well suited for a systems genetic approach 408
to study CCT. This relatively new branch of quantitative genetics has the goal of 409 understanding networks of interactions across multiple levels that link DNA 410 variation to phenotype [33] . The present approach involves an analysis of sets of 411 causal interactions among classic traits such as CCT, together with networks of 412 gene variants, and developmental/environmental factors. The main challenge is 413 the need for a comparatively large sample size and the use of more advanced 414 statistical and computational methods and models. The BXD strain set is 415 sufficiently large to have adequate power for this approach [34, 35] . The genetic 416 reference panel used in this study consisted of 62 strains of mice. The novel 417 aspect of our current approach is the combination of phenotypic mouse data, 418 mRNA expression data (baseline and experimental) from the same BXD RI 419 strains and the interrogation of GWAS studies for glaucoma (NEIGHBORHOOD 420 Study [25] ) and for CCT [22] . Data that we generated throughout this experiment 421 and data already deposited in GeneNetwork (www.genenetwork.org) for gene 422 expression in the eye [34] and retina [36] [37] [38] were used to test specific 423 mechanisms and predictions. 424
425
In the present study, we have identified a significant QTL on Chr 13 (13-19 Mb) 426 that modulates CCT in the BXD RI strain set. One suggestive QTL was also 427 In humans, CCT is a highly heritable trait affected by many genomic loci [16] [17] [18] [19] [20] [21] [22] . 441
Comparing these human loci to those identified in the mouse reveals several 442 genomic regions that are similar. For example, the mouse locus on Chr7 at 443 105Mb [39] could include previously identified human loci near several known 444 genes: TJP1, CHSY1, LRRK1 and AKAP13 [22, 41] . Other than this region in the 445 mouse, there does not appear to be any overlap between loci modulating CCT in 446 the mouse and those identified in the human. Many studies in human and mouse have looked for a genetic link between CCT 470 and glaucoma. Studies in the human cornea have found several SNPs that 471 modulate corneal thickness. However, none of the genes in these studies appear 472
to relate CCT to the risk of developing glaucoma with the exception of FNDC3B 473 [22] . Several studies have examined the genomic loci in the mouse that modulate 474 CCT and again none of the loci controlling CCT thickness relate to glaucoma 475 risk. In the present study, we have identified a well-defined QTL associated with 476 CCT in the mouse. Within this locus, there is a limited number of candidate 477 genes. One gene, Pou6f2, is uniquely poised to modulate CCT, for we have 478
shown that it is expressed in the developing cornea and in limbal stem cells. In 479 addition, Pou6f2 may also be associated with glaucoma risk. Interestingly, Zhou be selectively sensitive to loss in mouse models of glaucoma. In the present 493 study, we have also shown that Pou6f2 is expressed in the developing cornea 494 and corneal stem cells. When we examined the NEIGHBORHOOD database, 495 POU6F2 has an interesting association with POAG. However, for the 496 International Glaucoma Genetics Consortium dataset for CCT [22] the P value 497 was p = 0.0037, and when corrected for multiple testing it did not reach a 498 significant level. Thus, we are not able to definitively say that Pou6F2 is a 499 molecular link between CCT and glaucoma. As discussed above, CCT is a highly 500 heritable trait and it is the second highest risk factor for glaucoma, following IOP. 501
If this is the case, then why do we not know the molecular link between CCT and 502 POAG? Some phenotypic traits are very complex or even hyper-complex. A well-503 known example of a complex trait is height. It is estimated that there are over 504 2,000 genomic loci that may contribute to height and that the heritability is 505 relatively high as much as 80% [59] , although others estimate that the heritability 506 is lower due to dependence on family-based studies indicating that the true 507 heritability is between 60% to 70% [60] . Nonetheless, the weight of any one 508 genomic locus influencing height in the human population is low and genetic 509 components known to be associated with heritability can only be accounted for a 510 portion of the heritability. That being said, CCT is a glaucoma risk factor and a 511 highly heritable trait. The identification of molecular links connecting CCT to 512 POAG may be complicated by the fact that both are complex traits, influenced by 513 multiple genomic as well as environmental factors. Using a mouse model like the 514 BXD RI strain set (a restricted genetic reference panel) is an effective approach 515 to identify genomic elements modulating phenotypes such as CCT. These data 516
can now be used to design experiments that will attempt to link CCT to potential 517 glaucoma risk. 518 519 POU6F2 appears to mark a subpopulation of RGCs that are selectively sensitive 520 to injury in the DBA/2J mouse model of glaucoma. To understand the potential 521 role of POU6F2 we examined data from a ChIP-chip experiment [61] in HEK293 522 cells. In this human cell line, POU6F2 bound to a number of different targets: 523 CHD5, DACH1, ELAVL3, GFRA2, GRIN1, LHX1, MTSS1, NAP1L3, NEFH, 524 NPTX1, NR4A2, NTNG2, PCDH7, ROBO2, SLC30A3, SLC7A8, SORCS2, 525 UNC5A and VGF. If we examine these targets in the DoD Normal Retina 526
Database [37] on GeneNetwork, all of the targets are expressed at relatively high 527 levels in the retina, at least 2-fold above the mean expression of mRNA. In 528 addition, their expression levels are highly correlated across the BXD strain set, 529 with most probes having a Pearson's r value above 0.7. One of these down-530 stream targets, Slc30a3, encodes a zinc transporter (ZNT3). Recent studies from 531 the Benowitz lab [62], reveal that ZNT3 plays an important role in injured 532 ganglion cells and axon regeneration. Thus, it is tempting to hypothesize that 533 POU6F2 exerts its effects on retinal ganglion cell survival in an injury and chronic 534 neurodegeneration (glaucoma) context by modulation of Slc30a3. 535
536
In conclusion, we have shown that POU6F2 is involved in corneal development 537 and modulates CCT. In retinal ganglion cells, POU6F2 is a transcription factor 538 marking a subtype that is selectively sensitive to injury. POU6F2 is also known to 539 be upstream of genes that play a critical role in ganglion cell death following 540 injury and it is a potential glaucoma risk factor in humans. 541 542 543
Materials and Methods
545
Mice 546
All of the procedures involving mice were approved by IACUC at Emory 547
University and the University of Tennessee Health Science Center. The study 548 adhered to the ARVO Statement for the Use of Animals in Research. All of the 549 mice in this study were between 60 to 110 days of age, which is long before any 550 significant elevation in IOP due to two gene mutations (Tyrp1 and Gpnmb) 551 carried by selected BXD strains originating from the DBA/2J mouse. We 552 examined equivalent numbers of males and females for each of the strains. Mice 553 were housed in a pathogen-free facility at UTHSC or at Emory University, 554 maintained on a 12 hr light/dark cycle, and provided with food and water ad 555 libitum. All CCT measurements on the Pou6f2-null and wild-type mice were 556 performed in a double-blind manner. The mice were genotyped after all CCT 557 measurements were made. 558 559 Measuring CCT 560 CCT was measured using two different Ocular Coherence Tomography (OCT) 561 systems: a Bioptigen SD-OCT system (Morrisville, NC) and a Phoenix Micron IV 562
OCT Imaging system (Pleasanton, CA). Mice were anesthetized using ketamine 563 100mg/kg and xylazine 15mg/kg. The eye was positioned in front of the lens. The 564 entire anterior chamber was imaged. The corneal scans were saved to a portable 565 hard drive for subsequent analysis. CCT was then measured three times for 566 each eye using the Mouse Retina Program, InVivoVue Clinic, in the Bioptigen 567 Software or the Micron OCT software. These data were stored and entered into 568 an Excel spreadsheet. Repetitive measures were possible with the BXD RI 569 strains since each strain has the identical genetic background allowing us to 570 sample the developmental consequences of the same genetic background for all 571 independent measures. For the BXD strains the corneas were measured 572 between 60 and 90 days. In the Pou6f2-null mice the corneal thickness was 573 measured at 30 days of age. 574 575
Optic Nerve Crush 576
Optic nerve crush was performed as described in Templeton and Geisert [63] . 577
Briefly, three C57BL/6J mice were anesthetized using ketamine 100mg/kg and 578 xylazine 15mg/kg. Under the binocular operating scope a small incision was 579 made in the conjunctiva. With micro-forceps (Dumont #5/45 Forceps, Roboz, Gaithersburg, MD) , the edge of the conjunctiva was grasped next to 581 the globe. The globe was rotated nasally to allow visualization of the posterior 582 aspect of the globe and optic nerve. The exposed optic nerve is then clamped 2 583 mm from the optic nerve head with Dumont #N7 self-closing forceps (Roboz, cat. in the WebQTL module of GeneNetwork [64, 65] . Empirical significance 596 thresholds of linkage were determined by permutations [66] . We correlated 597 phenotypes with expression data for whole eye and retina generated by Geisert, 598 Lu and colleagues [34, 37] . Based on recent work with the enlarged set of BXDs, 599
we expected all significant (p < 0.05) QTLs to be mapped with a precision of ± 2 600
Mb [35, [67] [68] [69] . To identify loci, and also to nominate candidate genes, we used 601 the following approaches: interval mapping for the traditional phenotypes, 602 candidate gene selection within the QTL region, cis-eQTL analysis of gene 603 expression, trans-eQTL analysis, multi-trait and complex analysis of molecular, 604 clinical, and laboratory traits. 605 606
NEIGHBORHOOD Analysis 607
The peak area of association on mouse chromosome 13 was examined for 608 associations in human datasets. Syntenic regions on human chromosomes 1 609 and 7 were queried for associations with POAG in the NEIGHBORHOOD [ Twelve C57BL/6J mice were deeply anesthetized with a mixture of 15 mg/kg of 636 xylazine and 100 mg/kg of ketamine and perfused through the heart with saline 637 followed by 4% paraformaldehyde in phosphate buffer (pH 7.3). The eyes were 638 removed and embedded in paraffin and sectioned at 5µm. For the embryonic 639 eyes, two timed-pregnant female mice were deeply anesthetized with 640 tribromoethanol, decapitated and the E16 embryos were removed. The embryo 641 heads were placed in 4% paraformaldehyde on ice for 1 hour, rinsed with PBS 642 and dehydrated in stages of ethanol followed by xylenes, and then embedded in 643 paraffin. The 5µm sections of retina and E16 mice had the paraffin removed and 644 the sections were blocked with 5% normal donkey serum and stained with a 645 rabbit antiserum directed against POU6F2 (MyBiosource, Cat. # MBS9402684) 646 at 1:500 for 2 hours at room temperature (Supplemental Data 2, S1 Appendix). 647
To demonstrate the specificity of the POU6F2 antibody, retinas from Pou6f2-null 648 mice were stained and no nuclear labeling was observed. The sections were 649 rinsed three times and transferred to secondary antibodies (Alexa Fluor 488 650
AffiniPure Donkey Anti-Rabbit, Jackson Immunoresearch, Cat. #715-545-152; at 651 1:1000 for two hours at room temperature. After three washes of 15 minutes 652 each, To-PRO-3 Iodide (Molecular Probes, Cat. # T3605) was applied 1:1000 as 653 a nuclear counterstain. After a final wash in PBS, coverslips were placed over the 654 sections using Fuoromount -G (Southern Biotech, Cat. #0100-01) as a mounting 655 medium. For the retina flat mounts, the retinas were removed from the globe and 656 labeled with Alexa 594 (#705-585, Jackson ImmunoResearch Laboratories, West 688
Gove CA) at 4 °C overnight. The tissue was cut into 5 pieces, radially mounted 689 on a glass slide and a cover slip was placed over the tissue. 690 691 Acknowledgements 692
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